Multicentre, retrospective study to assess long-term outcomes of chelator based treatment with trientine in Wilson disease patients withdrawn from therapy with d-penicillamine
Conclusions
TETA-2HCl is well-tolerated and effective in Wilson disease patients following the withdrawal of treatment with D-penicillamine. ClinicalTrials.govIdentifier: NCT02426905.
Source: European Journal of Gastroenterology and Hepatology - Category: Gastroenterology Tags: Original Articles: Hepatology Source Type: research
More News: Anemia | Brain | Copper | Gastroenterology | Liver | Liver Transplant | Neurology | Study | Transplant Surgery | Transplants | Urology & Nephrology | Wilson's Disease | Zinc